Invivyd IVVD
NASDAQ IVVD
$0.61 +0.00 (+0.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Invivyd (IVVD) EBIT Margin (2024 - 2026)

Updated

Invivyd's EBIT Margin came in at -320.76% for Q2 2026, down 192.98 percentage points from -127.78% a year earlier.

Analysis

Invivyd (IVVD) EBIT Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Invivyd reported EBIT Margin of -149.73%, up 95.94 percentage points year-over-year; for FY2025, it came in at -103.99%, up 592.81 percentage points from FY2024.

  • Going back by year, EBIT Margin was -696.80% in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q3 2024.
  • Year-over-year, EBIT Margin increased in three of the last four quarters, with an average year-over-year change of +626.67 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Invivyd 196.17 Mn -310.47 Mn 13.01 Mn -320.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -320.76%
Dec 31, 2025 -72.96%
Sep 30, 2025 -83.96%
Jun 30, 2025 -127.78%
Mar 31, 2025 -149.70%
Dec 31, 2024 -139.14%
Sep 30, 2024 -670.01%
Jun 30, 2024 -2,175.22%
API Access

Invivyd EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY